ReviewItalian journal of pediatrics2019

Omalizumab and mepolizumab in the landscape of biological therapy for severe asthma in children: how to choose?

Mattia Giovannini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.